This inventor holds 2 USPTO granted patents. Top assignee: Technion Research & Development Foundation Ltd. Active years: 2014-2016.
Company Filing History:
Years Active: 2014-2016
Title: Henk Verheul: Innovator in Chemotherapeutic Treatments
Introduction
Henk Verheul is a notable inventor based in Amstelveen, Netherlands. He has made significant contributions to the field of medical treatments, particularly in the area of chemotherapeutic agents. With a total of 2 patents, his work focuses on innovative approaches to treating proliferative diseases.
Latest Patents
Henk Verheul's latest patents include a groundbreaking treatment utilizing hydrophobic weak bases as chemotherapeutic agents. These compounds, which are not anthracyclines, are designed for use in treating medical conditions characterized by proliferating cells. The treatment combines these hydrophobic weak base compounds with illumination of the affected area, enhancing their effectiveness as photosensitizers when exposed to specific wavelengths of light.
Career Highlights
Henk Verheul is associated with the Technion Research & Development Foundation Ltd., where he continues to advance his research and innovations. His work has the potential to significantly impact the treatment of various medical conditions, providing new avenues for therapy.
Collaborations
Henk has collaborated with notable colleagues, including Yamit Adar Turgeman and Arjan Willem Griffioen. These partnerships have contributed to the development and refinement of his innovative treatments.
Conclusion
Henk Verheul stands out as an inventor dedicated to improving medical treatments through innovative approaches. His contributions to the field of chemotherapeutics highlight the importance of research and collaboration in advancing healthcare solutions.